Update on developments with SGLT2 inhibitors in the management of type 2 diabetes

Abstract

The importance of the kidney's role in glucose homeostasis has gained wider understanding in recent years. Consequently, the development of a new pharmacological class of anti-diabetes agents targeting the kidney has provided new treatment options for the management of type 2 diabetes mellitus (T2DM). Sodium glucose co-transporter type 2 (SGLT2) inhibitors… (More)
DOI: 10.2147/DDDT.S50773

Topics

8 Figures and Tables

Cite this paper

@inproceedings{Nauck2014UpdateOD, title={Update on developments with SGLT2 inhibitors in the management of type 2 diabetes}, author={Michael A Nauck}, booktitle={Drug design, development and therapy}, year={2014} }